Prognostic Value of Combining Apelin-12 and Estimated Glomerular Filtration Rate in Patients with ST-Segment Elevation Myocardial Infarction

Background. Apelin-12 and estimated glomerular filtration rate (eGFR) are considered prognostic factors for ST-segment elevation myocardial infarction (STEMI). However, little is known about whether the combined use of these two biomarkers could enhance the prognostic value. This study aimed to inve...

Full description

Saved in:
Bibliographic Details
Main Authors: Yue Liu, Huasong Xia, Meng Li, Yi Chen, Yanqing Wu
Format: Article
Language:English
Published: Wiley 2022-01-01
Series:Journal of Interventional Cardiology
Online Access:http://dx.doi.org/10.1155/2022/2272928
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832549148419686400
author Yue Liu
Huasong Xia
Meng Li
Yi Chen
Yanqing Wu
author_facet Yue Liu
Huasong Xia
Meng Li
Yi Chen
Yanqing Wu
author_sort Yue Liu
collection DOAJ
description Background. Apelin-12 and estimated glomerular filtration rate (eGFR) are considered prognostic factors for ST-segment elevation myocardial infarction (STEMI). However, little is known about whether the combined use of these two biomarkers could enhance the prognostic value. This study aimed to investigate the utility of combining apelin-12 and eGFR for STEMI. Methods. Patients were divided into four groups based on median apelin-12 level and eGFR level: A: low apelin-12, low eGFR; B: low apelin-12, high eGFR; C: high apelin-12, low eGFR; and D: high apelin-12, high eGFR. The Cox regression was used to identify prognostic factors. The Kaplan–Meier and the receiver operating characteristic (ROC) curves were generated to evaluate the prognostic value of apelin-12 combined with eGFR in patients with STEMI. Results. Among 460 patients, 118 (25.7%) experienced major adverse cardiac events (MACEs) during the entire follow-up of 30 months. The Kaplan–Meier curve analysis revealed that group D had the best prognosis compared with the other three groups. The combination of apelin-12 and eGFR (area under the ROC curve (AUC), 0.699) enhanced the predictive value for MACE compared with either apelin-12 (AUC, 0.617) or eGFR (AUC, 0.596) alone. There was a negative association between apelin-12 and eGFR (r = −0.32, p<0.001), while no association was observed between the Gensini score and apelin-12 or eGFR. Conclusions. This study suggests that both low apelin-12 (<0.76 ng/ml) and low eGFR (<94.06 mL/min/1.73 m2) are associated with poor prognosis in STEMI, indicating that the combination of apelin-12 and eGFR could enhance the prognostic value of patients with STEMI.
format Article
id doaj-art-1e8cff393df7440eb1130433e0de9836
institution Kabale University
issn 1540-8183
language English
publishDate 2022-01-01
publisher Wiley
record_format Article
series Journal of Interventional Cardiology
spelling doaj-art-1e8cff393df7440eb1130433e0de98362025-02-03T06:11:55ZengWileyJournal of Interventional Cardiology1540-81832022-01-01202210.1155/2022/2272928Prognostic Value of Combining Apelin-12 and Estimated Glomerular Filtration Rate in Patients with ST-Segment Elevation Myocardial InfarctionYue Liu0Huasong Xia1Meng Li2Yi Chen3Yanqing Wu4Department of CardiologyDepartment of CardiologyDepartment of CardiologyDepartment of CardiologyDepartment of CardiologyBackground. Apelin-12 and estimated glomerular filtration rate (eGFR) are considered prognostic factors for ST-segment elevation myocardial infarction (STEMI). However, little is known about whether the combined use of these two biomarkers could enhance the prognostic value. This study aimed to investigate the utility of combining apelin-12 and eGFR for STEMI. Methods. Patients were divided into four groups based on median apelin-12 level and eGFR level: A: low apelin-12, low eGFR; B: low apelin-12, high eGFR; C: high apelin-12, low eGFR; and D: high apelin-12, high eGFR. The Cox regression was used to identify prognostic factors. The Kaplan–Meier and the receiver operating characteristic (ROC) curves were generated to evaluate the prognostic value of apelin-12 combined with eGFR in patients with STEMI. Results. Among 460 patients, 118 (25.7%) experienced major adverse cardiac events (MACEs) during the entire follow-up of 30 months. The Kaplan–Meier curve analysis revealed that group D had the best prognosis compared with the other three groups. The combination of apelin-12 and eGFR (area under the ROC curve (AUC), 0.699) enhanced the predictive value for MACE compared with either apelin-12 (AUC, 0.617) or eGFR (AUC, 0.596) alone. There was a negative association between apelin-12 and eGFR (r = −0.32, p<0.001), while no association was observed between the Gensini score and apelin-12 or eGFR. Conclusions. This study suggests that both low apelin-12 (<0.76 ng/ml) and low eGFR (<94.06 mL/min/1.73 m2) are associated with poor prognosis in STEMI, indicating that the combination of apelin-12 and eGFR could enhance the prognostic value of patients with STEMI.http://dx.doi.org/10.1155/2022/2272928
spellingShingle Yue Liu
Huasong Xia
Meng Li
Yi Chen
Yanqing Wu
Prognostic Value of Combining Apelin-12 and Estimated Glomerular Filtration Rate in Patients with ST-Segment Elevation Myocardial Infarction
Journal of Interventional Cardiology
title Prognostic Value of Combining Apelin-12 and Estimated Glomerular Filtration Rate in Patients with ST-Segment Elevation Myocardial Infarction
title_full Prognostic Value of Combining Apelin-12 and Estimated Glomerular Filtration Rate in Patients with ST-Segment Elevation Myocardial Infarction
title_fullStr Prognostic Value of Combining Apelin-12 and Estimated Glomerular Filtration Rate in Patients with ST-Segment Elevation Myocardial Infarction
title_full_unstemmed Prognostic Value of Combining Apelin-12 and Estimated Glomerular Filtration Rate in Patients with ST-Segment Elevation Myocardial Infarction
title_short Prognostic Value of Combining Apelin-12 and Estimated Glomerular Filtration Rate in Patients with ST-Segment Elevation Myocardial Infarction
title_sort prognostic value of combining apelin 12 and estimated glomerular filtration rate in patients with st segment elevation myocardial infarction
url http://dx.doi.org/10.1155/2022/2272928
work_keys_str_mv AT yueliu prognosticvalueofcombiningapelin12andestimatedglomerularfiltrationrateinpatientswithstsegmentelevationmyocardialinfarction
AT huasongxia prognosticvalueofcombiningapelin12andestimatedglomerularfiltrationrateinpatientswithstsegmentelevationmyocardialinfarction
AT mengli prognosticvalueofcombiningapelin12andestimatedglomerularfiltrationrateinpatientswithstsegmentelevationmyocardialinfarction
AT yichen prognosticvalueofcombiningapelin12andestimatedglomerularfiltrationrateinpatientswithstsegmentelevationmyocardialinfarction
AT yanqingwu prognosticvalueofcombiningapelin12andestimatedglomerularfiltrationrateinpatientswithstsegmentelevationmyocardialinfarction